{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:03:00Z","timestamp":1791428580902,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cjco.2025.09.015","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:34:23Z","timestamp":1759635263000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Detecting Polyneuropathy in Patients with Hereditary Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2169-3730","authenticated-orcid":false,"given":"Priya","family":"Arivalagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Carrasco","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Nugaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Katzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamsheed","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Santo","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2025.09.015_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges","volume":"21","author":"Carvalho","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cjco.2025.09.015_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14797\/mdcvj.1066","article-title":"ATTR epidemiology, genetics, and prognostic factors","volume":"18","author":"Obi","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.cjco.2025.09.015_bib3","series-title":"Cardiac amyloidosis","author":"Shams","year":"2022"},{"key":"10.1016\/j.cjco.2025.09.015_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-021-01706-7","article-title":"Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups","volume":"16","author":"Rintell","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjco.2025.09.015_bib5","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.09.015_bib6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1055\/a-0848-9610","article-title":"Neue therapieoptionen f\u00fcr die heredit\u00e4re transthyretin-amyloidose [Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)]","volume":"144","author":"Zibert","year":"2019","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.cjco.2025.09.015_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.09.015_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.09.015_bib9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3390\/jcm11082148","article-title":"Treatment of transthyretin amyloid cardiomyopathy: the current options, the future, and the challenges","volume":"11","author":"Tsch\u00f6pe","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjco.2025.09.015_bib10","doi-asserted-by":"crossref","first-page":"e2036","DOI":"10.1212\/WNL.0000000000207158","article-title":"Phenotypes associated with the Val122Ile, Leu58His, and late-onset Val30Met variants in patients with hereditary transthyretin amyloidosis","volume":"100","author":"Zampino","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.cjco.2025.09.015_bib11","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3390\/ijms24043554","article-title":"Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options","volume":"24","author":"Galiero","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cjco.2025.09.015_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution","volume":"14","author":"Poterucha","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2025.09.015_bib13","first-page":"718","article-title":"Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer","volume":"36","author":"Piccolo","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjco.2025.09.015_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjco.2025.09.015_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13023-020-01633-z","article-title":"Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus","volume":"15","author":"Grandis","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjco.2025.09.015_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-444-64032-1.00014-X","article-title":"Nerve conduction studies: basic concepts","volume":"160","author":"Tavee","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cjco.2025.09.015_bib17","first-page":"123","article-title":"Maintenance of skin temperature at the extremities in neuropathy and pain disorders","volume":"25","author":"Baron","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.cjco.2025.09.015_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2007.01.011","article-title":"The electrodiagnosis of neuropathy: basic principles and common pitfalls","volume":"25","author":"Gooch","year":"2007","journal-title":"Neurol Clin"},{"key":"10.1016\/j.cjco.2025.09.015_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42466-019-0035-z","article-title":"Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas","volume":"1","author":"Thimm","year":"2019","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.cjco.2025.09.015_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s42269-020-00352-6","article-title":"Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy","volume":"44","author":"Hewedi","year":"2020","journal-title":"Bull Natl Res Cent"},{"key":"10.1016\/j.cjco.2025.09.015_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/jnnp-2020-323787","article-title":"Chronic inflammatory axonal polyneuropathy","volume":"91","author":"Oh","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cjco.2025.09.015_bib23","author":"Rosario"},{"key":"10.1016\/j.cjco.2025.09.015_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13506129.2021.1976751","article-title":"Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type","volume":"29","author":"Papagianni","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.cjco.2025.09.015_bib25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cjco.2025.09.015_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.1015545","article-title":"Current and potential therapeutic strategies for transthyretin cardiac amyloidosis","volume":"2","author":"Williams","year":"2022","journal-title":"Front Drug Discov"},{"key":"10.1016\/j.cjco.2025.09.015_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13023-020-1340-x","article-title":"Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study","volume":"15","author":"In\u00eas","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjco.2025.09.015_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0972-2327.41875","article-title":"Diagnostic approach to peripheral neuropathy","volume":"11","author":"Misra","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.cjco.2025.09.015_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jns.12403","article-title":"Peripheral neuropathy symptoms in wild type transthyretin amyloidosis","volume":"25","author":"Wajnsztajn Yungher","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.cjco.2025.09.015_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/cjn.2020.271","article-title":"Utility of neuropathy screening for wild-type transthyretin amyloidosis patients","volume":"48","author":"Russell","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.cjco.2025.09.015_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/13506129.2021.2014448","article-title":"Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis","volume":"29","author":"Kleefeld","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.cjco.2025.09.015_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1345608","article-title":"Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center's experience","volume":"11","author":"\u017divkovi\u0107","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjco.2025.09.015_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003356","article-title":"Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: a systematic review","volume":"14","author":"Chandrashekar","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjco.2025.09.015_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13023-021-01910-5","article-title":"Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden","volume":"16","author":"Gonz\u00e1lez-Moreno","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjco.2025.09.015_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2024.4631","article-title":"Five-year results with patisiran for hereditary transthyretin amyloidosis with polyneuropathy: a randomized clinical trial with open-label extension","volume":"82","author":"Adams","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cjco.2025.09.015_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1756285612470192","article-title":"Recent advances in the treatment of familial amyloid polyneuropathy","volume":"6","author":"Adams","year":"2013","journal-title":"Ther Adv Neurol Disord"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25005931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25005931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:48:22Z","timestamp":1773323302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X25005931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2589790X25005931"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2025.09.015","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting Polyneuropathy in Patients with Hereditary Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2025.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}